Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-30 @ 10:28 PM
Study NCT ID:
NCT04972656
Status:
RECRUITING
Last Update Posted:
2022-09-28
First Post:
2021-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Sponsor:
Nanjing First Hospital, Nanjing Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-09
First Submit QC Date:
None
Study First Post Date:
2021-07-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-27
Last Update Post Date:
2022-09-28
Last Update Post Date Type:
ACTUAL